Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
収録刊行物
-
- Supportive Care in Cancer
-
Supportive Care in Cancer 19 (8), 1217-1225, 2010-06-25
Springer Science and Business Media LLC